Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

Frailty assessment in older adults using upper-extremity function: index development.

Toosizadeh N, Wendel C, Hsu CH, Zamrini E, Mohler J.

BMC Geriatr. 2017 Jun 2;17(1):117. doi: 10.1186/s12877-017-0509-1.

2.

A phase 3 trial of IV immunoglobulin for Alzheimer disease.

Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2017 May 2;88(18):1768-1775. doi: 10.1212/WNL.0000000000003904. Epub 2017 Apr 5.

PMID:
28381506
3.

Added value and limitations of amyloid-PET imaging: review and analysis of selected cases of mild cognitive impairment and dementia.

Weidman DA, Zamrini E, Sabbagh MN, Jacobson S, Burke A, Belden C, Powell J, Bhalla N, Roontiva A, Kuang X, Luo J, Chen K, Riggs G, Burke W.

Neurocase. 2017 Feb;23(1):41-51. doi: 10.1080/13554794.2017.1290806. Epub 2017 Feb 21.

PMID:
28376695
4.

Screening for dementia in Arabic: normative data from an elderly Lebanese sample.

Abou-Mrad F, Chelune G, Zamrini E, Tarabey L, Hayek M, Fadel P.

Clin Neuropsychol. 2017 Feb 23:1-19. doi: 10.1080/13854046.2017.1288270. [Epub ahead of print]

PMID:
28276861
5.

Progression of brain atrophy in PSP and CBS over 6 months and 1 year.

Dutt S, Binney RJ, Heuer HW, Luong P, Attygalle S, Bhatt P, Marx GA, Elofson J, Tartaglia MC, Litvan I, McGinnis SM, Dickerson BC, Kornak J, Waltzman D, Voltarelli L, Schuff N, Rabinovici GD, Kramer JH, Jack CR Jr, Miller BL, Rosen HJ, Boxer AL; AL-108-231 investigators.

Neurology. 2016 Nov 8;87(19):2016-2025. Epub 2016 Oct 14.

6.

Upper-Extremity Dual-Task Function: An Innovative Method to Assess Cognitive Impairment in Older Adults.

Toosizadeh N, Najafi B, Reiman EM, Mager RM, Veldhuizen JK, O'Connor K, Zamrini E, Mohler J.

Front Aging Neurosci. 2016 Jul 7;8:167. doi: 10.3389/fnagi.2016.00167. eCollection 2016.

7.

A multicenter study of the early detection of synaptic dysfunction in Mild Cognitive Impairment using Magnetoencephalography-derived functional connectivity.

Maestú F, Peña JM, Garcés P, González S, Bajo R, Bagic A, Cuesta P, Funke M, Mäkelä JP, Menasalvas E, Nakamura A, Parkkonen L, López ME, Del Pozo F, Sudre G, Zamrini E, Pekkonen E, Henson RN, Becker JT; Magnetoencephalography International Consortium of Alzheimer's Disease.

Neuroimage Clin. 2015 Aug 1;9:103-9. doi: 10.1016/j.nicl.2015.07.011. eCollection 2015.

8.

Sociolinguistic reflection on neuropsychological assessment: an insight into selected culturally adapted battery of Lebanese Arabic cognitive testing.

Abou-Mrad F, Tarabey L, Zamrini E, Pasquier F, Chelune G, Fadel P, Hayek M.

Neurol Sci. 2015 Oct;36(10):1813-22. doi: 10.1007/s10072-015-2257-3. Epub 2015 May 27.

PMID:
26012851
9.

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial.

Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, Roberson ED, Höglinger GU, Koestler M, Jack CR Jr, Van Deerlin V, Randolph C, Lobach IV, Heuer HW, Gozes I, Parker L, Whitaker S, Hirman J, Stewart AJ, Gold M, Morimoto BH; AL-108-231 Investigators.

Lancet Neurol. 2014 Jul;13(7):676-85. doi: 10.1016/S1474-4422(14)70088-2. Epub 2014 May 27.

10.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

11.

Magnetoencephalography as a putative biomarker for Alzheimer's disease.

Zamrini E, Maestu F, Pekkonen E, Funke M, Makela J, Riley M, Bajo R, Sudre G, Fernandez A, Castellanos N, Del Pozo F, Stam CJ, van Dijk BW, Bagic A, Becker JT.

Int J Alzheimers Dis. 2011 Apr 10;2011:280289. doi: 10.4061/2011/280289.

12.

Validation of consensus panel diagnosis in dementia.

Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust WJ, Kawas CH, Koeppe RA, Leverenz JB, Lipton AM, Peskind ER, Turner RS, Womack KB, Zamrini EY.

Arch Neurol. 2010 Dec;67(12):1506-12. doi: 10.1001/archneurol.2010.301.

13.

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust WJ, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, DeKosky ST, Farlow MR, Gabel MJ, Higdon R, Kawas CH, Koeppe RA, Lipton AM, Foster NL.

Arch Neurol. 2011 Mar;68(3):329-37. doi: 10.1001/archneurol.2010.295. Epub 2010 Nov 8.

14.

Clinical interview assessment of financial capacity in older adults with mild cognitive impairment and Alzheimer's disease.

Marson DC, Martin RC, Wadley V, Griffith HR, Snyder S, Goode PS, Kinney FC, Nicholas AP, Steele T, Anderson B, Zamrini E, Raman R, Bartolucci A, Harrell LE.

J Am Geriatr Soc. 2009 May;57(5):806-14. doi: 10.1111/j.1532-5415.2009.02202.x. Epub 2009 Apr 21.

15.

Epidemiology of stroke in chronic heart failure patients with normal sinus rhythm: findings from the DIG stroke sub-study.

Mujib M, Giamouzis G, Agha SA, Aban I, Sathiakumar N, Ekundayo OJ, Zamrini E, Allman RM, Butler J, Ahmed A.

Int J Cardiol. 2010 Oct 29;144(3):389-93. doi: 10.1016/j.ijcard.2009.04.035. Epub 2009 May 12.

16.

Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development.

Foster NL, Andersen TC, Zamrini EY.

Alzheimers Dement. 2009 Mar;5(2):159-62. doi: 10.1016/j.jalz.2009.01.017.

PMID:
19328451
17.

Neurocognitive predictors of financial capacity across the dementia spectrum: Normal aging, mild cognitive impairment, and Alzheimer's disease.

Sherod MG, Griffith HR, Copeland J, Belue K, Krzywanski S, Zamrini EY, Harrell LE, Clark DG, Brockington JC, Powers RE, Marson DC.

J Int Neuropsychol Soc. 2009 Mar;15(2):258-67. doi: 10.1017/S1355617709090365. Epub 2009 Feb 10.

18.

Medical decision-making capacity in mild cognitive impairment: a 3-year longitudinal study.

Okonkwo OC, Griffith HR, Copeland JN, Belue K, Lanza S, Zamrini EY, Harrell LE, Brockington JC, Clark D, Raman R, Marson DC.

Neurology. 2008 Nov 4;71(19):1474-80. doi: 10.1212/01.wnl.0000334301.32358.48.

19.

Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease.

Li L, Cao D, Desmond R, Rahman A, Lah JJ, Levey AI, Zamrini E.

Dement Geriatr Cogn Disord. 2008;26(4):384-90. doi: 10.1159/000164271. Epub 2008 Oct 16.

20.

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ; Alzheimer Disease Cooperative Study.

JAMA. 2008 Oct 15;300(15):1774-83. doi: 10.1001/jama.300.15.1774.

Supplemental Content

Loading ...
Support Center